Daily Archives: September 7, 2012

15-03-2012 14:58 March 14, 2012 - Current Topics in Genome Analysis 2012 More:

Read more:

Genome-Wide Association Studies - Karen Mohlke (2012) - Video

04-04-2012 13:48 Google Tech Talk March 27, 2012 ABSTRACT It is often said that genomics science is on a Moore's law, growing exponentially in data throughput, number of assembled genomes, lowered cost, etc.; and yet, it has not delivered the biomedical promises made a decade ago: personalized medicine; genomic characterization of diseases like cancer, schizophrenia, and autism; bio-markers for common complex diseases; prenatal genomic assays, etc. What share of blame for this failure ought to be allocated to computer science (or computational biology, bioinformatics, statistical genetics, etc.)? How can the computational biology community lead genomics science to rescue it from the current impasse? What are the computational solutions to these problems? What should be our vision of computational biology in the coming decade? We will discuss three systems: TotalReCaller, SUTTA-Assembler and Feature-Response-Curves, in this context. For more info: About the speaker Professor Bud Mishra is a professor of computer science and mathematics at NYU's Courant Institute of Mathematical Sciences, professor of human genetics at Mt. Sinai School of Medicine, and a professor of cell biology at NYU School of Medicine. He founded the NYU/Courant Bioinformatics Group, a multi-disciplinary group working on research at the interface of computer science, applied mathematics, biology, biomedicine and bio/nano-technologies. Prof. Mishra has a degree in Physics from Utkal University, in ...

See the rest here:

The Genome Question: Moore vs. Jevons with Bud Mishra - Video

09-04-2012 05:36 This first half of the DNA analysis lecture reviews DNA sequencing, the human genome project, and the sequencing of the genome of other species. Arcadia University US275 Scientific Ethics.

Read more:

DNA analysis Part I. Genomic Sequencing - Video

13-04-2012 12:32 This is video footage of President William Jefferson Clinton speaking at an event in which it was announced that the first survey of the entire human genome had been completed, along with Dr. Francis Collins and Dr. J. Craig Venter. Prime Minister Tony Blair delivered remarks via satellite telecast. This footage is official public record produced by the White House Television (WHTV) crew, provided by the Clinton Presidential Library. Date: June 26, 2000 Location: East Room. White House. Washington, DC ARC Identifier: 5896781 Access Restriction(s): unrestricted Use Restrictions(s): unrestricted Camera: White House Television (WHTV) / Main Local Identifiers: MT11692, MT11693 This material is public domain, as it is a work prepared by an officer or employee of the US government as part of that person's official duties. Any usage must receive the credit "Courtesy; William J. Clinton Presidential Library," and no exclusive rights or permissions are granted for usage.

See original here:

Announcing the Completion of the First Survey of the Entire Human Genome at the White House - Video

19-04-2012 07:40 Human Genome's 'Blockbuster' Drug Benlystal Potential Undervalued in Bid by GSK vs HGSI BREAKING NEWS! Human Genome Rejects $2.6B Bid From GlaxoSmithKline (Update 1). The stock is currently trading at $14.50 up over 100% on a "MASSIVE SHORT SQUEEZE"! (SMF is long several long term calls on HGSI) Pre-Market Volume Alert! HGSI Buyout by GSK Rejected shares up 100%. Massive Short Squeeze Alert was given on HGSI on 1 Human Genome Sciences closed near $7 yesterday, but GlaxoSmithKline stunned investors with a $13-per share takeover offer! HGSI is doubling in the premarket, and is well above that bid price. Shares of Human Genome (HGSI) are rallying 109% in pre-market trading to $15.00 after the company disclosed that GlaxoSmithKline (GSK) made a $13.00 per share offer to acquire the company. Human Genone said the offer "does not reflect the value inherent in HGS" and hired Goldman Sachs as well as Credit Suisse to explore of strategic alternatives, including a potential sale.

Here is the original post:

Human Genome's 'Blockbuster' Potential Undervalued in Bid GSK vs HGSI - Video

19-04-2012 14:46 April 11, 2012 - Current Topics in Genome Analysis More:

Go here to see the original:

Genomic Medicine - Bruce Korf (2012) - Video